Skip to main content
Caplight Logo









inSEIT

inSEIT

Private
BernHealthcare & Life Scienceshttps://www.inseit.ch/

Last Round

Pre Seed

Oct 27, 2023

Total Funding Raised

$640,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

inSEIT is a biotechnology company that applies bioinformatic tools and novel screening technologies to develop tailored immobilized biocatalysts for the chemical and pharmaceutical industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

enzyme immobilizationindustrial biocatalysisbiocatalystbioinformaticsprotein engineeringcontract research organizationCROactive pharmaceutical ingredientAPIsynthetic biologysynbiopredictive modelinggreen chemistrysustainable manufacturingbiotech platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

inSEIT Comparables

Compare inSEIT with similar companies based on industry and business-model similarity.

inSEIT comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cascade Bio
88%
FabricNano
81%
ChiralVision B.V.
81%

inSEIT Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedOct 27, 2023
GrantAug 15, 2022
GrantJul 4, 2022

Key People

Founding team and executive leadership

Gordon Honeyman

Co-Founder And COO

Founding Team

David Roura Padrosa

Chief Executive Officer

Executive Team

inSEIT Investors

Notable investors and investment history

inSEIT investors
InvestorRounds
Swiss National Science FoundationGrant
ValueMaker AGPre Seed
BRIDGEPre Seed
VentureLabsPre Seed
Venture KickGrant
InnosuisseGrant, Pre Seed
BERNINVEST AGPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 169% MoM, reaching 1.9K.

  • May 16, 2026

    Monthly visitors grew 79% MoM, reaching 701.

inSEIT Filings

Explore SEC and related filing metadata, where available.

inSEIT filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about inSEIT's valuation, stock price, and market status.

Is inSEIT a public or private company?

inSEIT is a private company.

What is the current stock price of inSEIT?

inSEIT is a private company with no public stock price. No recent secondary market data is available.

How much is inSEIT worth (valuation)?

Valuation information for inSEIT is not publicly available.

Can I buy inSEIT stock?

inSEIT shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was inSEIT's last funding round?

inSEIT's most recent funding round was Pre Seed on October 23, 2023.

Who are the main investors in inSEIT?

Key investors in inSEIT include Swiss National Science Foundation, ValueMaker AG, BRIDGE, VentureLabs, Venture Kick.

Will inSEIT IPO soon?

No public IPO plans have been announced for inSEIT.

How can I track inSEIT secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor inSEIT's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBern
Employee Range4
Year Founded2022
Last FundingOct 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?